Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Twist Bioscience

Request full access

Develops a proprietary semiconductor-based synthetic DNA manufacturing process

South San Francisco, United StatesFounded 2013Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2018

Twist Bioscience in the South San Francisco ecosystem

Live from Dealroom

The Twist Bioscience office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

19 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later16 investors entered at this stage

  • Tao Venture Partners
  • Boris Nikolic
  • ARCH Overage Fund
  • FIS
  • WuXi Healthcare Ventures
  • Joby Pritzker
  • Reinet Investments S.C.A.
  • Dentsu Ventures
  • +ND Capital
  • 3W Partners
  • Biomatics Capital Partners
  • Illumina Ventures
  • Cormorant Asset Management
  • Foresite Capital
  • Yuri Milner
  • Illumina
Employees mapped 1,305 incl. 7 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$89M

108 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Twist Bioscience was the backer or acquirer, 2016–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Twist Bioscience's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Twist Bioscience deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Twist Bioscience's portfolio, mapped.

        Stage
        Period
        5 of 5 deals

        See Twist Bioscience on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.